Skip to main content

Table 4 New broncho-pulmonary colonization and antibiotic courses of pediatric cases and age-matched controls during the year after A/H1N1 2009 pandemic influenza

From: Lessons from a French collaborative case–control study in cystic fibrosis patients during the 2009 A/H1N1 influenza pandemy

  n Cases (n = 33) n Controls (n = 55) p
Age 33 9.7+/- 4.7 55 9.5+/- 4.8 0,9
Antibiotics, number of treatments, mean (SD)    
 Oral 33 2.7 (2.2) 55 2.4 (2.6) 0.40
 Intravenous 33 0.52 (1.12) 55 0.56 (2.01) 0.33
New bronchopulmonary colonization, n (%)    
 Any germ 33 13 (39) 55 26 (47) 0.47
H. influenza 33 1 (3) 55 9 (16) 0.04
S. aureus 33 3 (9) 55 6 (11) 0.78
P. aeruginosa 33 6 (18) 55 6 (11) 0.44
B. cepacia 33 0 55 1 (2) 0.40
A. fumigatus 33 3 (9) 55 4 (7) 0.94
Oxygen therapy, n (%) 33 0 (0) 55 0 (0) 1
Noninvasive ventilation, n (%) 33 0 (0) 55 0 (0) 1
  1. Both are compared to reference data and expressed as percent predicted values, based on age, gender, and height
  2. FEV1 forced expiratory volume in one second, FVC forced vital capacity, SD standard deviation